FMO5 and colorectal carcinoma: Moreover, we examined the protein levels of LC3 in CRC cells treated with CPX or/and apocynin, rotenone and nordihydroguaiaretic acid (NDGA) used to block NADPH oxidase, mitochondrial and 5-LOX-driven ROS release, respectively.